Last 12 months
Inside the activity.
0 purchase rows · 21 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 7,292 | $8.16 | $59,502.72 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 8 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,667 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 15 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,163 Underlying: Common Stock · 1,667 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 625 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 14 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 625 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the total number of shares vest monthly thereafter. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,042 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 13 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,076 Underlying: Common Stock · 1,042 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
SaleCommon Stock | 3,334 | $34.65 | $115,523.10 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 9 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,686 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted August 31, 2020. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionCommon Stock | 1,667 | $17.15 | $28,589.05 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 8 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionCommon Stock | 625 | $10.14 | $6,337.50 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 7 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionCommon Stock | 1,042 | $8.16 | $8,502.72 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 6 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · derivative · entry 14 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,549 Underlying: Common Stock · 30,000 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 1,100 | $40.01 | $44,015.95 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,319 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.91 to $40.16, inclusive. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 10,495 | $39.20 | $411,411.35 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,419 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.81 to $39.79, inclusive. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 3,581 | $38.55 | $138,059.01 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,914 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.81 to $38.79, inclusive. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 1,000 | $37.43 | $37,434.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,495 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.80 to $37.78, inclusive. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 3,600 | $35.95 | $129,432.96 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,495 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.66 to $36.64, inclusive. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 10,224 | $35.10 | $358,813.32 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,095 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $35.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (10) to this Form 4. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 30,000 | $17.15 | $514,500.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 22:14 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,326 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-045623 · doc4.xml · derivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,549 Underlying: Common Stock · 17,326 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 22:14 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 30,000 | $31.14 | $934,200.00 |
DisclosureSEC source: 0001209191-21-045623 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,319 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 22:14 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 17,326 | $17.15 | $297,140.90 |
DisclosureSEC source: 0001209191-21-045623 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 31,170 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 12 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,830 Underlying: Common Stock · 31,170 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 11 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,625 Underlying: Common Stock · 11,250 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the total number of shares vest monthly thereafter. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 18,420 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · derivative · entry 10 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,118 Underlying: Common Stock · 18,420 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
SaleCommon Stock | 20,000 | $40.02 | $800,320.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 5 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,686 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted August 31, 2020. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $40.00 to $40.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
SaleCommon Stock | 90,840 | $31.14 | $2,828,757.60 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 4 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,686 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted August 31, 2020. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionCommon Stock | 31,170 | $17.15 | $534,565.50 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 3 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionCommon Stock | 11,250 | $10.14 | $114,075.00 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 2 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:38 UTC |
Yu CalvinVice President, Finance
|
Exercise / conversionCommon Stock | 18,420 | $8.16 | $150,307.20 |
DisclosureSEC source: 0001209191-21-045930 · doc4.xml · nonDerivative · entry 1 Yu Calvin · CIK 0001757799 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:02 UTC |
King RobertChief Development Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-045916 · doc4.xml · derivative · entry 5 King Robert · CIK 0001635264 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 30,000 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the option vested on November 1, 2019, and one forty-eighth (1/48th) of the shares subject to the option vest each month thereafter. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:02 UTC |
King RobertChief Development Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-045916 · doc4.xml · derivative · entry 4 King Robert · CIK 0001635264 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 30,000 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:02 UTC |
King RobertChief Development Officer
|
SaleCommon Stock | 60,000 | $31.14 | $1,868,400.00 |
DisclosureSEC source: 0001209191-21-045916 · doc4.xml · nonDerivative · entry 3 King Robert · CIK 0001635264 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,317 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 19, 2020. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:02 UTC |
King RobertChief Development Officer
|
Exercise / conversionCommon Stock | 30,000 | $10.14 | $304,200.00 |
DisclosureSEC source: 0001209191-21-045916 · doc4.xml · nonDerivative · entry 2 King Robert · CIK 0001635264 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 19:02 UTC |
King RobertChief Development Officer
|
Exercise / conversionCommon Stock | 30,000 | $8.16 | $244,800.00 |
DisclosureSEC source: 0001209191-21-045916 · doc4.xml · nonDerivative · entry 1 King Robert · CIK 0001635264 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 552,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Aug 9, 2021 22:13 UTC |
SCHELLER RICHARD HDirector
|
SaleCommon Stock | 9,981 | $31.14 | $310,808.34 |
DisclosureSEC source: 0001209191-21-050471 · doc4.xml · nonDerivative · entry 1 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 22:14 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 26,726 | $22.23 | $594,124.33 |
DisclosureSEC source: 0001209191-21-045623 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,993 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 20:58 UTC |
MCGUIRE TERRANCEDirector
|
GrantStock Option (right to buy) · Derivative | 25,709 | $0.00 Strike: $21.37 | $0.00 |
DisclosureSEC source: 0001209191-21-042422 · doc4.xml · derivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,709 Underlying: Common Stock · 25,709 shares Expires 2031-06-17 F1 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2021 and vest in full on the earlier of the date of the Issuer's next annual meeting of stockholders or June 17, 2022. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 20:43 UTC |
Hammond PaulaDirector
|
GrantStock Option (right to buy) · Derivative | 25,709 | $0.00 Strike: $21.37 | $0.00 |
DisclosureSEC source: 0001209191-21-042415 · doc4.xml · derivative · entry 1 Hammond Paula · CIK 0001805348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,709 Underlying: Common Stock · 25,709 shares Expires 2031-06-17 F1 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2021 and vest in full on the earlier of the date of the Issuer's next annual meeting of stockholders or June 17, 2022. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 16:39 UTC |
Gerngross Tillman U.Director
|
GrantStock Option (right to buy) · Derivative | 25,709 | $0.00 Strike: $21.37 | $0.00 |
DisclosureSEC source: 0001209191-21-042410 · doc4.xml · derivative · entry 1 Gerngross Tillman U. · CIK 0001722061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,709 Underlying: Common Stock · 25,709 shares Expires 2031-06-17 F1 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2021 and vest in full on the earlier of the date of the Issuer's next annual meeting of stockholders or June 17, 2022. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 20:48 UTC |
LAVIGNE LOUIS J JRDirector
|
GrantStock Option (right to buy) · Derivative | 25,709 | $0.00 Strike: $21.37 | $0.00 |
DisclosureSEC source: 0001209191-21-042417 · doc4.xml · derivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,709 Underlying: Common Stock · 25,709 shares Expires 2031-06-17 F1 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2021 and vest in full on the earlier of the date of the Issuer's next annual meeting of stockholders or June 17, 2022. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:05 UTC |
SCHELLER RICHARD HDirector
|
GrantStock Option (right to buy) · Derivative | 25,709 | $0.00 Strike: $21.37 | $0.00 |
DisclosureSEC source: 0001209191-21-042431 · doc4.xml · derivative · entry 1 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,709 Underlying: Common Stock · 25,709 shares Expires 2031-06-17 F1 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2021 and vest in full on the earlier of the date of the Issuer's next annual meeting of stockholders or June 17, 2022. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:09 UTC |
Wehner David M.Director
|
GrantStock Option (right to buy) · Derivative | 25,709 | $0.00 Strike: $21.37 | $0.00 |
DisclosureSEC source: 0001209191-21-042440 · doc4.xml · derivative · entry 1 Wehner David M. · CIK 0001534965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,709 Underlying: Common Stock · 25,709 shares Expires 2031-06-17 F1 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2021 and vest in full on the earlier of the date of the Issuer's next annual meeting of stockholders or June 17, 2022. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:13 UTC |
Yaffe KristineDirector
|
GrantStock Option (right to buy) · Derivative | 25,709 | $0.00 Strike: $21.37 | $0.00 |
DisclosureSEC source: 0001209191-21-042446 · doc4.xml · derivative · entry 1 Yaffe Kristine · CIK 0001783895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,709 Underlying: Common Stock · 25,709 shares Expires 2031-06-17 F1 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2021 and vest in full on the earlier of the date of the Issuer's next annual meeting of stockholders or June 17, 2022. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:15 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,600 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · derivative · entry 8 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,867 Underlying: Common Stock · 4,600 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:15 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 4,600 | $22.18 | $102,048.70 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $22.54, inclusive. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:15 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 4,600 | $10.14 | $46,644.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 21, 2021 20:15 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,900 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · derivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,467 Underlying: Common Stock · 12,900 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| June 15, 2021 Filed Jun 21, 2021 20:15 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,100 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · derivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,983 Underlying: Common Stock · 17,100 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 15, 2021 Filed Jun 21, 2021 20:15 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 30,000 | $22.07 | $661,953.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.305, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 21, 2021 20:15 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 12,900 | $10.14 | $130,806.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 21, 2021 20:15 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 17,100 | $8.16 | $139,536.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:24 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,883 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-039571 · doc4.xml · derivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,284 Underlying: Common Stock · 11,883 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.